Chiesi Austria Belgium France Germany Italy Netherlands Spain Switzerland United States of America Massachusetts
07.08.2025 - 18:06:01Chiesi explores the impact of climate change on people living with respiratory conditions in the series The Climate and Us
About Chiesi Group
Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company's mission is to improve people's quality of life and act responsibly towards both the community and the environment.
By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi's commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, we're part of a global community of businesses that meet high standards of social and environmental impact. The company aims to reach Net-Zero greenhouse gases (GHG) emissions by 2035.
With over 85 years of experience, Chiesi is headquartered in Parma (Italy), operates in 31 countries, and counts more than 6,500 employees. The Group's research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden.
For further information please visit www.chiesi.com
About the Global Climate and Health Alliance
The Global Climate and Health Alliance was formed in Durban in 2011 to tackle climate change and to protect and promote public health. The Alliance is made up of health and development organisations from around the world united by a shared vision of an equitable, sustainable future. Our vision is a world in which the health impacts of climate change are kept to a minimum, and the health co-benefits of climate change mitigation are maximised.
The Alliance was launched following the inaugural Climate and Health summit, which took place in 2011 during the 17th Conference of the Parties (COP17) to the United Nations Framework Convention on Climate Change (UNFCCC).
1 https://www.who.int/news/item/24-05-2023-wha76-strategic-roundtable-on-health-and-climate
https://www.eib.org/en/stories/the-climate-crisis-is-also-a-health-crisis
2 Economist Impact. Cleaner air, clearer lungs, better lives: exploring the intersection of air quality, health inequalities and lung health. London: Economist Impact, 2023. Available from: https://impact.economist.com/perspectives/health/cleaner-air-clearer-lungs-better-lives
* The new inhalers, containing a more climate-friendly propellant gas, are still in active pharmaceutical development and initial availability on the market will vary by Country and product.
View original content:https://www.prnewswire.com/news-releases/chiesi-explores-the-impact-of-climate-change-on-people-living-with-respiratory-conditions-in-the-series-the-climate-and-us-302005127.html